Immunic Inc (NASDAQ:IMUX) shares, rose in value on Wednesday, June 18, with the stock price down by -2.75% to the previous day’s close as strong demand from buyers drove the stock to $0.75.
Actively observing the price movement in the last trading, the stock closed the session at $0.77. Referring to stock’s 52-week performance, its high was $2.11, and the low was $0.56. On the whole, IMUX has fluctuated by -22.31% over the past month.
With the market capitalization of Immunic Inc currently standing at about $71.52 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-15.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IMUX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IMUX currently trading nearly -8.25% and -20.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.47, while the 7-day volatility ratio is showing 3.69% which for the 30-day chart, stands at 7.77%. Furthermore, Immunic Inc (IMUX)’s beta value is 1.49, and its average true range (ATR) is 0.08.
A comparison of Immunic Inc (IMUX) with its peers suggests the former has fared considerably weaker in the market. IMUX showed an intraday change of -2.75% in last session, and over the past year, it shrunk by -37.28%%.
Data on historical trading for Immunic Inc (NASDAQ:IMUX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.39 million. According to company’s latest data on outstanding shares, there are 95.82 million shares outstanding.
Nearly 3.40% of Immunic Inc’s shares belong to company insiders and institutional investors own 40.58% of the company’s shares. The stock has fallen by -25.36% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IMUX stock heading into the next quarter.
